IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 310 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $223,000 | -53.0% | 5,587 | -30.4% | 0.01% | -72.0% |
| Q2 2020 | $474,000 | +123.6% | 8,033 | +95.5% | 0.02% | +212.5% |
| Q3 2018 | $212,000 | -12.8% | 4,110 | -29.6% | 0.01% | -20.0% |
| Q2 2018 | $243,000 | -3.6% | 5,842 | +1.1% | 0.01% | 0.0% |
| Q1 2018 | $252,000 | -11.3% | 5,777 | +2.3% | 0.01% | -23.1% |
| Q4 2017 | $284,000 | -4.1% | 5,647 | -3.4% | 0.01% | -18.8% |
| Q3 2017 | $296,000 | – | 5,848 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |